Monograph - Perspectives In Central Nervous System Malignancies
Activity Date: July 2008 — Activity Info: Volume 1, (1)
 

Full Disclosure Policy Affecting CME Activities: As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of The Johns Hopkins University School of Medicine to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The Course Directors and Participating Faculty reported the following:

COURSE DIRECTORS

Stuart A. Grossman, MD
Professor, Oncology, Medicine, and Neurosurgery
The Johns Hopkins University
Baltimore, Maryland
Dr Grossman reports having no significant financial or advisory relationships with
corporate organizations related to this activity.

Martin J. van den Bent, MD, PhD
Professor, Department of Neuro-Oncology
Daniel den Hoed Cancer Center
Erasmus University Medical Center
Rotterdam, The Netherlands
Dr van den Bent reports receiving grants/research support from Novartis
Pharmaceuticals Corporation; serving as a consultant for Adnexus, Novartis
Pharmaceuticals Corporation, and Schering-Plough Corporation; and serving on the
speakers’ bureau for Schering-Plough Corporation.

W. K. Alfred Yung, MD
Chairman, Department of Neuro-Oncology
Margaret and Ben Love Chair of Clinical Cancer Care
MD Anderson Cancer Center
Houston, Texas
Dr Yung reports receiving grants/research support from Genentech, Inc, Novartis
Pharmaceuticals Corporation, and Schering-Plough Corporation; serving as a consultant
for and receiving honoraria from Myriad, Novartis Pharmaceuticals Corporation, and Schering-Plough Corporation; and serving on the speakers’ bureau for Schering-Plough Corporation.

PARTICIPATING FACULTY

Brigitta G. Baumert, MD, PhD
Radiation Oncologist
Department of Radiation-Oncology (MAASTRO)
Grow (Research Institute Growth and Development)
Maastricht University Medical Center
Maastricht, The Netherlands
Dr Baumert reports having no significant financial or advisory relationships with corporate organizations related to this activity.

Matthias Preusser, MD
Neurooncologist
Medical University of Vienna
Vienna, Austria
Dr Preusser reports having no significant financial or advisory relationships with corporate organizations related to this activity.

Walter Taal, MD
Neurooncologist
Department of Neuro-Oncology
Daniel den Hoed Cancer Center
Erasmus University Medical Center
Rotterdam, The Netherlands
Dr Taal reports having no significant financial or advisory relationships with corporate organizations related to this activity.

Stefaan Van Gool, MD, PhD
Kliniekhoofd, Buitengewoon Hoogleraar
Pediatric Hemato-oncology and Neuro-oncology
University Hospital Gasthuisberg
Laboratory of Experimental Immunology
Leuven, Belgium
Dr Van Gool reports having no significant financial or advisory relationships with corporate organizations related to this activity.

Notice: No faculty member has indicated that his or her article will include information on off-label products.

Johns Hopkins Advanced Studies in Oncology provides disclosure information from contributing authors, lead presenters, and participating faculty. Johns Hopkins Advanced Studies in Oncology does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.

     
Home | Contact Us | View Account | Need Help?